DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
-2.61%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$43.4B
AUM Growth
-$1.09B
(-2.4%)
Cap. Flow
+$59.4M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
24.12%
Holding
1,560
New
305
Increased
525
Reduced
442
Closed
68
Top Buys
| 1 |
CRH
CRH
|
+$217M |
| 2 |
Meta Platforms (Facebook)
META
|
+$199M |
| 3 |
Exelon
EXC
|
+$99.8M |
| 4 |
MetLife
MET
|
+$89.1M |
| 5 |
Eli Lilly
LLY
|
+$70.3M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$150M |
| 2 |
Amgen
AMGN
|
+$96.4M |
| 3 |
Applied Materials
AMAT
|
+$73.6M |
| 4 |
Parker-Hannifin
PH
|
+$69.4M |
| 5 |
Microsoft
MSFT
|
+$66.7M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Healthcare | 17.93% |
| 3 | Financials | 10.39% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Concentrix
CNXC
$3.25B
| $668K | ﹤0.01% |
8,626
| – | – |
|
952
Spire
SR
$4.5B
| $667K | ﹤0.01% |
11,996
| – | – |
|
953
A10 Networks
ATEN
$1.26B
| $663K | ﹤0.01% |
44,500
| – | – |
|
954
Alector
ALEC
$287M
| $662K | ﹤0.01% |
100,000
| – | – |
|
955
Regenxbio
RGNX
$483M
| $661K | ﹤0.01% |
37,600
| – | – |
|
956
News Corp Class A
NWSA
$16.2B
| $660K | ﹤0.01% |
33,142
+387
| +1% | +$7.71K |
|
957
Tencent Music
TME
$39.2B
| $660K | ﹤0.01% |
108,185
+19,824
| +22% | +$121K |
|
958
Tango Therapeutics
TNGX
$708M
| $653K | ﹤0.01% |
+60,000
| New | +$653K |
|
|
AZPN
959
DELISTED
Aspen Technology Inc
AZPN
| $652K | ﹤0.01% |
3,189
+47
| +1% | +$9.61K |
|
960
Pliant Therapeutics
PLRX
$104M
| $648K | ﹤0.01% |
40,000
| – | – |
|
|
VERV
961
DELISTED
Verve Therapeutics
VERV
| $648K | ﹤0.01% |
50,000
| – | – |
|
962
BILL Holdings
BILL
$5.38B
| $647K | ﹤0.01% |
6,229
-1,151
| -16% | -$120K |
|
963
GFL Environmental
GFL
$17.2B
| $647K | ﹤0.01% |
20,228
+404
| +2% | +$12.9K |
|
964
COPT Defense Properties
CDP
$3.45B
| $641K | ﹤0.01% |
26,964
| – | – |
|
965
Xencor
XNCR
$596M
| $640K | ﹤0.01% |
31,800
| – | – |
|
966
DiamondRock Hospitality
DRH
$1.72B
| $639K | ﹤0.01% |
80,429
+27,648
| +52% | +$220K |
|
967
Broadstone Net Lease
BNL
$3.52B
| $626K | ﹤0.01% |
44,455
| – | – |
|
968
Varonis Systems
VRNS
$6.31B
| $625K | ﹤0.01% |
20,500
| – | – |
|
969
PTC Therapeutics
PTCT
$4.63B
| $622K | ﹤0.01% |
27,976
+3,976
| +17% | +$88.4K |
|
970
Cal-Maine
CALM
$5.31B
| $619K | ﹤0.01% |
12,710
| – | – |
|
971
Veracyte
VCYT
$2.42B
| $618K | ﹤0.01% |
27,297
+3,097
| +13% | +$70.1K |
|
972
LXP Industrial Trust
LXP
$2.67B
| $613K | ﹤0.01% |
69,306
| – | – |
|
973
Amylyx Pharmaceuticals
AMLX
$1.05B
| $610K | ﹤0.01% |
33,000
| – | – |
|
974
MINISO
MNSO
$7.73B
| $606K | ﹤0.01% |
23,261
+9,203
| +65% | +$240K |
|
975
Pacific Biosciences
PACB
$366M
| $605K | ﹤0.01% |
73,300
| – | – |
|